Specific Celiac Disease Antibodies in Children on a Gluten-Free Diet

Celiac disease (CD) is characterized by histologic alterations in small bowel biopsies. Circulating specific CD antibodies at the time of diagnosis and their disappearance after a gluten-free diet support the diagnosis of CD. We aimed to determine the behavior of the CD antibodies immunoglobulin A a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatrics (Evanston) 2011-09, Vol.128 (3), p.547-552
Hauptverfasser: HOGEN ESCH, Caroline E, WOLTERS, Victorien M, GERRITSEN, Susan A. M, PUTTER, Hein, MARY VON BLOMBERG, B, VAN HOOGSTRATEN, Ingrid M. W, HOUWEN, Roderick H. J, DER LELY, Nico Van, LUISA MEARIN, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 552
container_issue 3
container_start_page 547
container_title Pediatrics (Evanston)
container_volume 128
creator HOGEN ESCH, Caroline E
WOLTERS, Victorien M
GERRITSEN, Susan A. M
PUTTER, Hein
MARY VON BLOMBERG, B
VAN HOOGSTRATEN, Ingrid M. W
HOUWEN, Roderick H. J
DER LELY, Nico Van
LUISA MEARIN, M
description Celiac disease (CD) is characterized by histologic alterations in small bowel biopsies. Circulating specific CD antibodies at the time of diagnosis and their disappearance after a gluten-free diet support the diagnosis of CD. We aimed to determine the behavior of the CD antibodies immunoglobulin A anti-tissue transglutaminase (anti-TG2) and immunoglobulin A endomysium (EMA) in children with CD after starting a gluten-free diet. This was a retrospective multicenter study in the Netherlands between 2001 and 2009. Inclusion criteria were all newly diagnosed patients with CD younger than 19 years who had at least 1 anti-TG2 and/or EMA measurement before and after starting a gluten-free diet. Eight different anti-TG2 kits were used with substrates of guinea pig TG2 in 1 (Sigma) and 7 human-recombinant TG2: Varelisa and EliA Celikey Phadia-GmbH; Orgentec Diagnostica-GmbH; Diarect AG; Roboscreen GmbH; Aeskulisa Diagnostics; Binding Site Ltd. EMA was analyzed with indirect immunofluorescence tests. Statistical analyses were performed by using mixed-model repeated measurements and survival analysis. There were 129 children with CD included (mean age: 5.6 years; SD ± 4.2). The mean concentration of anti-TG2 decreased significantly within 3 months after starting a gluten-free diet (P < .0001). The cumulative percentage of children who became negative for EMA after ½, 1, 1½, and 2 years was 31%, 60%, 74%, and 87%, respectively. For anti-TG2, a comparable trend was shown: 35%, 55%, 64%, and 78%, respectively. Doctors taking care of children with CD should be aware that the mean concentration of anti-TG2 will show a 74% decrease (95% confidence interval: 69%-79%) after 3 months of gluten-free diet, and ∼80% of the children will be sero-negative for EMA and anti-TG2 after 2 years of the diet.
doi_str_mv 10.1542/peds.2010-3762
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_923191330</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A267296880</galeid><sourcerecordid>A267296880</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-3e82bfab2ae3ec192945b9fce233c7641e74799091af4f229b1d17fe38638bb33</originalsourceid><addsrcrecordid>eNpd0U1v1DAQBmALgejS9soRRUgVpyy2x4nt4yr9AKlSD8DZcpxJceV1FjuR4N_jaJci9eTL49E78xLyntEtawT_fMAhbzlltAbZ8ldkw6hWteCyeU02lAKrBaXNGXmX8xOlVDSSvyVnnKlGawYbcv3tgM6P3lUdBm9dde0z2ozVLs6-nwaPufKx6n76MCSM1RQrW92FZcZY3ybE4nG-IG9GGzJent5z8uP25nv3pb5_uPva7e5rB0rPNaDi_Wh7bhHQMc21aHo9OuQATraCoRRSa6qZHcXIue7ZwOSIoFpQfQ9wTj4d5x7S9GvBPJu9zw5DsBGnJRvNgZWtgBb58YV8mpYUSzijNEjRAhcF1Uf0aAMaH90UZ_w9uykEfERToncPZsdbyXWr1Dp0e_QuTTknHM0h-b1NfwyjZm3DrG2YtQ2ztlE-fDilWPo9Ds_83_kLuDoBm50NY7LR-fzfCdGWuAB_AfqAjzg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>893746324</pqid></control><display><type>article</type><title>Specific Celiac Disease Antibodies in Children on a Gluten-Free Diet</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>HOGEN ESCH, Caroline E ; WOLTERS, Victorien M ; GERRITSEN, Susan A. M ; PUTTER, Hein ; MARY VON BLOMBERG, B ; VAN HOOGSTRATEN, Ingrid M. W ; HOUWEN, Roderick H. J ; DER LELY, Nico Van ; LUISA MEARIN, M</creator><creatorcontrib>HOGEN ESCH, Caroline E ; WOLTERS, Victorien M ; GERRITSEN, Susan A. M ; PUTTER, Hein ; MARY VON BLOMBERG, B ; VAN HOOGSTRATEN, Ingrid M. W ; HOUWEN, Roderick H. J ; DER LELY, Nico Van ; LUISA MEARIN, M</creatorcontrib><description>Celiac disease (CD) is characterized by histologic alterations in small bowel biopsies. Circulating specific CD antibodies at the time of diagnosis and their disappearance after a gluten-free diet support the diagnosis of CD. We aimed to determine the behavior of the CD antibodies immunoglobulin A anti-tissue transglutaminase (anti-TG2) and immunoglobulin A endomysium (EMA) in children with CD after starting a gluten-free diet. This was a retrospective multicenter study in the Netherlands between 2001 and 2009. Inclusion criteria were all newly diagnosed patients with CD younger than 19 years who had at least 1 anti-TG2 and/or EMA measurement before and after starting a gluten-free diet. Eight different anti-TG2 kits were used with substrates of guinea pig TG2 in 1 (Sigma) and 7 human-recombinant TG2: Varelisa and EliA Celikey Phadia-GmbH; Orgentec Diagnostica-GmbH; Diarect AG; Roboscreen GmbH; Aeskulisa Diagnostics; Binding Site Ltd. EMA was analyzed with indirect immunofluorescence tests. Statistical analyses were performed by using mixed-model repeated measurements and survival analysis. There were 129 children with CD included (mean age: 5.6 years; SD ± 4.2). The mean concentration of anti-TG2 decreased significantly within 3 months after starting a gluten-free diet (P &lt; .0001). The cumulative percentage of children who became negative for EMA after ½, 1, 1½, and 2 years was 31%, 60%, 74%, and 87%, respectively. For anti-TG2, a comparable trend was shown: 35%, 55%, 64%, and 78%, respectively. Doctors taking care of children with CD should be aware that the mean concentration of anti-TG2 will show a 74% decrease (95% confidence interval: 69%-79%) after 3 months of gluten-free diet, and ∼80% of the children will be sero-negative for EMA and anti-TG2 after 2 years of the diet.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.2010-3762</identifier><identifier>PMID: 21859913</identifier><identifier>CODEN: PEDIAU</identifier><language>eng</language><publisher>Elk Grove Village, IL: American Academy of Pediatrics</publisher><subject>Antibodies, Anti-Idiotypic - immunology ; Autoantibodies - immunology ; Biological and medical sciences ; Care and treatment ; Celiac disease ; Celiac Disease - diet therapy ; Celiac Disease - immunology ; Child ; Child, Preschool ; Childrens health ; Demographic aspects ; Diet ; Diet, Gluten-Free ; Female ; Fluorescent Antibody Technique, Indirect ; Gastroenterology. Liver. Pancreas. Abdomen ; General aspects ; Gluten-free diet ; GTP-Binding Proteins - immunology ; Humans ; Immunoglobulin A ; Immunoglobulin A - immunology ; Immunoglobulins ; Infant ; Intestinal Mucosa - immunology ; Male ; Measurement ; Medical sciences ; Other diseases. Semiology ; Patient outcomes ; Pediatrics ; Retrospective Studies ; Rodents ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Transglutaminases ; Transglutaminases - immunology</subject><ispartof>Pediatrics (Evanston), 2011-09, Vol.128 (3), p.547-552</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright American Academy of Pediatrics Sep 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-3e82bfab2ae3ec192945b9fce233c7641e74799091af4f229b1d17fe38638bb33</citedby><cites>FETCH-LOGICAL-c389t-3e82bfab2ae3ec192945b9fce233c7641e74799091af4f229b1d17fe38638bb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24468933$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21859913$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HOGEN ESCH, Caroline E</creatorcontrib><creatorcontrib>WOLTERS, Victorien M</creatorcontrib><creatorcontrib>GERRITSEN, Susan A. M</creatorcontrib><creatorcontrib>PUTTER, Hein</creatorcontrib><creatorcontrib>MARY VON BLOMBERG, B</creatorcontrib><creatorcontrib>VAN HOOGSTRATEN, Ingrid M. W</creatorcontrib><creatorcontrib>HOUWEN, Roderick H. J</creatorcontrib><creatorcontrib>DER LELY, Nico Van</creatorcontrib><creatorcontrib>LUISA MEARIN, M</creatorcontrib><title>Specific Celiac Disease Antibodies in Children on a Gluten-Free Diet</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>Celiac disease (CD) is characterized by histologic alterations in small bowel biopsies. Circulating specific CD antibodies at the time of diagnosis and their disappearance after a gluten-free diet support the diagnosis of CD. We aimed to determine the behavior of the CD antibodies immunoglobulin A anti-tissue transglutaminase (anti-TG2) and immunoglobulin A endomysium (EMA) in children with CD after starting a gluten-free diet. This was a retrospective multicenter study in the Netherlands between 2001 and 2009. Inclusion criteria were all newly diagnosed patients with CD younger than 19 years who had at least 1 anti-TG2 and/or EMA measurement before and after starting a gluten-free diet. Eight different anti-TG2 kits were used with substrates of guinea pig TG2 in 1 (Sigma) and 7 human-recombinant TG2: Varelisa and EliA Celikey Phadia-GmbH; Orgentec Diagnostica-GmbH; Diarect AG; Roboscreen GmbH; Aeskulisa Diagnostics; Binding Site Ltd. EMA was analyzed with indirect immunofluorescence tests. Statistical analyses were performed by using mixed-model repeated measurements and survival analysis. There were 129 children with CD included (mean age: 5.6 years; SD ± 4.2). The mean concentration of anti-TG2 decreased significantly within 3 months after starting a gluten-free diet (P &lt; .0001). The cumulative percentage of children who became negative for EMA after ½, 1, 1½, and 2 years was 31%, 60%, 74%, and 87%, respectively. For anti-TG2, a comparable trend was shown: 35%, 55%, 64%, and 78%, respectively. Doctors taking care of children with CD should be aware that the mean concentration of anti-TG2 will show a 74% decrease (95% confidence interval: 69%-79%) after 3 months of gluten-free diet, and ∼80% of the children will be sero-negative for EMA and anti-TG2 after 2 years of the diet.</description><subject>Antibodies, Anti-Idiotypic - immunology</subject><subject>Autoantibodies - immunology</subject><subject>Biological and medical sciences</subject><subject>Care and treatment</subject><subject>Celiac disease</subject><subject>Celiac Disease - diet therapy</subject><subject>Celiac Disease - immunology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Childrens health</subject><subject>Demographic aspects</subject><subject>Diet</subject><subject>Diet, Gluten-Free</subject><subject>Female</subject><subject>Fluorescent Antibody Technique, Indirect</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>General aspects</subject><subject>Gluten-free diet</subject><subject>GTP-Binding Proteins - immunology</subject><subject>Humans</subject><subject>Immunoglobulin A</subject><subject>Immunoglobulin A - immunology</subject><subject>Immunoglobulins</subject><subject>Infant</subject><subject>Intestinal Mucosa - immunology</subject><subject>Male</subject><subject>Measurement</subject><subject>Medical sciences</subject><subject>Other diseases. Semiology</subject><subject>Patient outcomes</subject><subject>Pediatrics</subject><subject>Retrospective Studies</subject><subject>Rodents</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Transglutaminases</subject><subject>Transglutaminases - immunology</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpd0U1v1DAQBmALgejS9soRRUgVpyy2x4nt4yr9AKlSD8DZcpxJceV1FjuR4N_jaJci9eTL49E78xLyntEtawT_fMAhbzlltAbZ8ldkw6hWteCyeU02lAKrBaXNGXmX8xOlVDSSvyVnnKlGawYbcv3tgM6P3lUdBm9dde0z2ozVLs6-nwaPufKx6n76MCSM1RQrW92FZcZY3ybE4nG-IG9GGzJent5z8uP25nv3pb5_uPva7e5rB0rPNaDi_Wh7bhHQMc21aHo9OuQATraCoRRSa6qZHcXIue7ZwOSIoFpQfQ9wTj4d5x7S9GvBPJu9zw5DsBGnJRvNgZWtgBb58YV8mpYUSzijNEjRAhcF1Uf0aAMaH90UZ_w9uykEfERToncPZsdbyXWr1Dp0e_QuTTknHM0h-b1NfwyjZm3DrG2YtQ2ztlE-fDilWPo9Ds_83_kLuDoBm50NY7LR-fzfCdGWuAB_AfqAjzg</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>HOGEN ESCH, Caroline E</creator><creator>WOLTERS, Victorien M</creator><creator>GERRITSEN, Susan A. M</creator><creator>PUTTER, Hein</creator><creator>MARY VON BLOMBERG, B</creator><creator>VAN HOOGSTRATEN, Ingrid M. W</creator><creator>HOUWEN, Roderick H. J</creator><creator>DER LELY, Nico Van</creator><creator>LUISA MEARIN, M</creator><general>American Academy of Pediatrics</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>20110901</creationdate><title>Specific Celiac Disease Antibodies in Children on a Gluten-Free Diet</title><author>HOGEN ESCH, Caroline E ; WOLTERS, Victorien M ; GERRITSEN, Susan A. M ; PUTTER, Hein ; MARY VON BLOMBERG, B ; VAN HOOGSTRATEN, Ingrid M. W ; HOUWEN, Roderick H. J ; DER LELY, Nico Van ; LUISA MEARIN, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-3e82bfab2ae3ec192945b9fce233c7641e74799091af4f229b1d17fe38638bb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antibodies, Anti-Idiotypic - immunology</topic><topic>Autoantibodies - immunology</topic><topic>Biological and medical sciences</topic><topic>Care and treatment</topic><topic>Celiac disease</topic><topic>Celiac Disease - diet therapy</topic><topic>Celiac Disease - immunology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Childrens health</topic><topic>Demographic aspects</topic><topic>Diet</topic><topic>Diet, Gluten-Free</topic><topic>Female</topic><topic>Fluorescent Antibody Technique, Indirect</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>General aspects</topic><topic>Gluten-free diet</topic><topic>GTP-Binding Proteins - immunology</topic><topic>Humans</topic><topic>Immunoglobulin A</topic><topic>Immunoglobulin A - immunology</topic><topic>Immunoglobulins</topic><topic>Infant</topic><topic>Intestinal Mucosa - immunology</topic><topic>Male</topic><topic>Measurement</topic><topic>Medical sciences</topic><topic>Other diseases. Semiology</topic><topic>Patient outcomes</topic><topic>Pediatrics</topic><topic>Retrospective Studies</topic><topic>Rodents</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Transglutaminases</topic><topic>Transglutaminases - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HOGEN ESCH, Caroline E</creatorcontrib><creatorcontrib>WOLTERS, Victorien M</creatorcontrib><creatorcontrib>GERRITSEN, Susan A. M</creatorcontrib><creatorcontrib>PUTTER, Hein</creatorcontrib><creatorcontrib>MARY VON BLOMBERG, B</creatorcontrib><creatorcontrib>VAN HOOGSTRATEN, Ingrid M. W</creatorcontrib><creatorcontrib>HOUWEN, Roderick H. J</creatorcontrib><creatorcontrib>DER LELY, Nico Van</creatorcontrib><creatorcontrib>LUISA MEARIN, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HOGEN ESCH, Caroline E</au><au>WOLTERS, Victorien M</au><au>GERRITSEN, Susan A. M</au><au>PUTTER, Hein</au><au>MARY VON BLOMBERG, B</au><au>VAN HOOGSTRATEN, Ingrid M. W</au><au>HOUWEN, Roderick H. J</au><au>DER LELY, Nico Van</au><au>LUISA MEARIN, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Specific Celiac Disease Antibodies in Children on a Gluten-Free Diet</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>128</volume><issue>3</issue><spage>547</spage><epage>552</epage><pages>547-552</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><coden>PEDIAU</coden><abstract>Celiac disease (CD) is characterized by histologic alterations in small bowel biopsies. Circulating specific CD antibodies at the time of diagnosis and their disappearance after a gluten-free diet support the diagnosis of CD. We aimed to determine the behavior of the CD antibodies immunoglobulin A anti-tissue transglutaminase (anti-TG2) and immunoglobulin A endomysium (EMA) in children with CD after starting a gluten-free diet. This was a retrospective multicenter study in the Netherlands between 2001 and 2009. Inclusion criteria were all newly diagnosed patients with CD younger than 19 years who had at least 1 anti-TG2 and/or EMA measurement before and after starting a gluten-free diet. Eight different anti-TG2 kits were used with substrates of guinea pig TG2 in 1 (Sigma) and 7 human-recombinant TG2: Varelisa and EliA Celikey Phadia-GmbH; Orgentec Diagnostica-GmbH; Diarect AG; Roboscreen GmbH; Aeskulisa Diagnostics; Binding Site Ltd. EMA was analyzed with indirect immunofluorescence tests. Statistical analyses were performed by using mixed-model repeated measurements and survival analysis. There were 129 children with CD included (mean age: 5.6 years; SD ± 4.2). The mean concentration of anti-TG2 decreased significantly within 3 months after starting a gluten-free diet (P &lt; .0001). The cumulative percentage of children who became negative for EMA after ½, 1, 1½, and 2 years was 31%, 60%, 74%, and 87%, respectively. For anti-TG2, a comparable trend was shown: 35%, 55%, 64%, and 78%, respectively. Doctors taking care of children with CD should be aware that the mean concentration of anti-TG2 will show a 74% decrease (95% confidence interval: 69%-79%) after 3 months of gluten-free diet, and ∼80% of the children will be sero-negative for EMA and anti-TG2 after 2 years of the diet.</abstract><cop>Elk Grove Village, IL</cop><pub>American Academy of Pediatrics</pub><pmid>21859913</pmid><doi>10.1542/peds.2010-3762</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-4005
ispartof Pediatrics (Evanston), 2011-09, Vol.128 (3), p.547-552
issn 0031-4005
1098-4275
language eng
recordid cdi_proquest_miscellaneous_923191330
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Antibodies, Anti-Idiotypic - immunology
Autoantibodies - immunology
Biological and medical sciences
Care and treatment
Celiac disease
Celiac Disease - diet therapy
Celiac Disease - immunology
Child
Child, Preschool
Childrens health
Demographic aspects
Diet
Diet, Gluten-Free
Female
Fluorescent Antibody Technique, Indirect
Gastroenterology. Liver. Pancreas. Abdomen
General aspects
Gluten-free diet
GTP-Binding Proteins - immunology
Humans
Immunoglobulin A
Immunoglobulin A - immunology
Immunoglobulins
Infant
Intestinal Mucosa - immunology
Male
Measurement
Medical sciences
Other diseases. Semiology
Patient outcomes
Pediatrics
Retrospective Studies
Rodents
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Transglutaminases
Transglutaminases - immunology
title Specific Celiac Disease Antibodies in Children on a Gluten-Free Diet
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A26%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Specific%20Celiac%20Disease%20Antibodies%20in%20Children%20on%20a%20Gluten-Free%20Diet&rft.jtitle=Pediatrics%20(Evanston)&rft.au=HOGEN%20ESCH,%20Caroline%20E&rft.date=2011-09-01&rft.volume=128&rft.issue=3&rft.spage=547&rft.epage=552&rft.pages=547-552&rft.issn=0031-4005&rft.eissn=1098-4275&rft.coden=PEDIAU&rft_id=info:doi/10.1542/peds.2010-3762&rft_dat=%3Cgale_proqu%3EA267296880%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=893746324&rft_id=info:pmid/21859913&rft_galeid=A267296880&rfr_iscdi=true